全球、区域及国家层面原发性肝癌各亚型疾病负担
研究利用95个国家基于人群的癌症登记数据,按组织学亚型计算肝细胞癌(HCC)和肝内胆管癌(iCCA)的性别与国家分布,并应用于2018年全球癌症观察站数据。2018年全球肝癌约826000例,其中HCC 661000例(年龄标化发病率7.3/10万)、iCCA 123000例(1.4/10万)、其他明确组织学42000例(0.5/10万);HCC占全球负担80%、iCCA占14.9%、其他明确组织学占5.1%。
要点
- 2018年全球肝癌估计826000例,HCC占80%、iCCA占14.9%、其他明确组织学占5.1%。
- HCC年龄标化发病率最高为东亚14.8、北非13.2、东南亚9.5。
- iCCA年龄标化发病率最高为东南亚2.9、东亚2.0,北欧、加勒比及中美洲、大洋洲均为1.8。
核心结论
- 揭示肝癌主要亚型的独特分布模式很重要,这些估计对制定公共卫生政策以降低肝癌负担及监测全球HCC和iCCA控制进展至关重要。
研究设计与样本
- 基于95个国家癌症登记数据中按组织学亚型分类的肝癌病例,计算HCC、iCCA和其他明确组织学的性别与国家分布,并将其应用于全球癌症观察站2018年肝癌总病例估计,计算年龄标化发病率。
主要发现
- 2018年全球肝癌估计826000例:HCC 661000例(年龄标化发病率7.3/10万),iCCA 123000例(1.4/10万),其他明确组织学42000例(0.5/10万)。
- HCC占全球肝癌总负担80%,iCCA占14.9%,其他明确组织学占5.1%。
- HCC年龄标化发病率最高的地区为东亚14.8、北非13.2、东南亚9.5。
- iCCA年龄标化发病率最高的地区为东南亚2.9、东亚2.0,北欧、加勒比及中美洲、大洋洲均为1.8。
关键数值与推荐
- 全球2018年肝癌估计826000例,其中HCC 661000例(年龄标化发病率7.3/10万)、iCCA 123000例(1.4/10万)、其他明确组织学42000例(0.5/10万)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) are the two main histological subtypes of primary liver cancer. Estimates of the burden of liver cancer by subtype are needed to facilitate development and evaluation of liver cancer control globally. We provide worldwide, regional and national estimates of HCC and iCCA incidence using high-quality data. METHODS: We used population-based cancer registry data on liver cancer cases by histological subtype from 95 countries to compute the sex- and country-specific distributions of HCC, iCCA and other specified histology. Subtype distributions were applied to estimates of total liver cancer cases for 2018 from the Global Cancer Observatory. Age-standardised incidence rates (ASRs) were calculated. RESULTS: There were an estimated 826,000 cases of liver cancer globally in 2018: 661,000 HCC (ASR 7.3 cases per 100,000); 123,000 iCCA (ASR 1.4) and 42,000 other specified histology (ASR 0.5). HCC contributed 80% of the world total liver cancer burden followed by iCCA (14.9%) and other specified histology (5.1%). HCC rates were highest in Eastern Asia (ASR 14.8), Northern Africa (ASR 13.2) and South-Eastern Asia (ASR 9.5). Rates of iCCA were highest in South-Eastern Asia (ASR 2.9), Eastern Asia (ASR 2.0), Northern Europe, the Caribbean and Central America and Oceania (ASR all 1.8). CONCLUSION: We have shown the importance of uncovering the distinct patterns of the major subtypes of liver cancer. The use of these estimates is critical to further develop public health policy to reduce the burden of liver cancer and monitor progress in controlling HCC and iCCA globally.
引用
- Rumgay H, Ferlay J, de Martel C, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2021. PMID: 34942552. doi:10.1016/j.ejca.2021.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。